Karen Prange Insider Trading $ATRC AtriCure, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Karen Prange.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Karen Prange. Karen Prange is SVP&Pres, Uro & Pelvic Health in BOSTON SCIENTIFIC CORP ($BSX) and SVP&Pres, Uro & Women's Health in BOSTON SCIENTIFIC CORP ($BSX) and Director in CANTEL MEDICAL CORP ($CMN) and EVP&CEO Gl.AH.Med.Den.Sur.Grp in HENRY SCHEIN INC ($HSIC) and Director in AtriCure, Inc. ($ATRC) and Director in NEVRO CORP ($NVRO).

Karen Prange in AtriCure, Inc.

Trading Symbol: ATRC
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Karen Prange: Director
Holdings: 10,103 shares
Current Value: $172,054
Latest Transaction: May 24 2021
$ATRC Market Capitalization: $567.72M
$ATRC Previous Close: $17.03

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Karen Prange in AtriCure, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ATRC, BSX, CMN, HSIC, NVRO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 24 2021ATRCAtriCure, Inc.Prange KarenDirectorGrantA0.001,749010,1038.4 K to 10.1 K (+20.94 %)
May 24 2021ATRCAtriCure, Inc.Prange KarenDirectorGrantA0.001,749010,1038.4 K to 10.1 K (+20.94 %)
May 22 2020ATRCAtriCure, Inc.Prange KarenDirectorGrantA0.002,45208,3545.9 K to 8.4 K (+41.55 %)
Dec 05 2019ATRCAtriCure, Inc.Prange KarenDirectorGrantA0.005,90205,9020 to 5.9 K

Page:   1